New approaches in psychiatric drug development-Reference-Cited by-同舟云学术

New approaches in psychiatric drug development

Published:2018-09 Issue:9 Volume:28 Page:983-993
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

van der Doef Thalia F.,Zaragoza Domingo Silvia,Jacobs Gabriel E.,Drevets Wayne C.,Marston Hugh M.,Nathan Pradeep J.,Tome Maria B.,Tamminga Carol A.,van Gerven Joop M.A.,Kas Martien J.H.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference28 articles.

1. Bjornsson, T.D., 2016. Progression of Modern Therapeutics (2015 Report).

2. Identification of distinct psychosis biotypes using brain-based biomarkers;Clementz;Am. J. Psychiatry,2016

3. The use of biomarkers in human pharmacology (Phase I) studies;Cohen;Annu. Rev. Pharmacol. Toxicol,2015

4. A new initiative on precision medicine;Collins;N. Engl. J. Med,2015

5. Mechanism-based pharmacokinetic–pharmacodynamic modeling—a new classification of biomarkers;Danhof;Pharm. Res.,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials;European Neuropsychopharmacology;2024-06

2. Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs;Translational Psychiatry;2023-03-01

3. Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder;Neuropharmacology;2023-03

4. The Role of fMRI in Drug Development: An Update;Advances in Neurobiology;2023

5. The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders;Advances in Neurobiology;2023